- Home
- EVTV vs CNSP Comparison
EVTV vs CNSP Comparison
Compare EVTV & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVTV
- CNSP
- Stock Information
- Founded
- EVTV 2012
- CNSP 2017
- Country
- EVTV United States
- CNSP United States
- Employees
- EVTV N/A
- CNSP N/A
- Industry
- EVTV Auto Manufacturing
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- EVTV Consumer Discretionary
- CNSP Health Care
- Exchange
- EVTV Nasdaq
- CNSP Nasdaq
- Market Cap
- EVTV 5.4M
- CNSP 5.6M
- IPO Year
- EVTV 2017
- CNSP 2019
- Fundamental
- Price
- EVTV $0.25
- CNSP $1.04
- Analyst Decision
- EVTV
- CNSP Hold
- Analyst Count
- EVTV 0
- CNSP 1
- Target Price
- EVTV N/A
- CNSP N/A
- AVG Volume (30 Days)
- EVTV 114.6K
- CNSP 224.0K
- Earning Date
- EVTV 04-15-2025
- CNSP 05-14-2025
- Dividend Yield
- EVTV N/A
- CNSP N/A
- EPS Growth
- EVTV N/A
- CNSP N/A
- EPS
- EVTV N/A
- CNSP N/A
- Revenue
- EVTV $1,870,060.00
- CNSP N/A
- Revenue This Year
- EVTV N/A
- CNSP N/A
- Revenue Next Year
- EVTV N/A
- CNSP N/A
- P/E Ratio
- EVTV N/A
- CNSP N/A
- Revenue Growth
- EVTV N/A
- CNSP N/A
- 52 Week Low
- EVTV $0.23
- CNSP $0.77
- 52 Week High
- EVTV $2.61
- CNSP $800.00
- Technical
- Relative Strength Index (RSI)
- EVTV 41.27
- CNSP 36.68
- Support Level
- EVTV $0.23
- CNSP $0.83
- Resistance Level
- EVTV $0.27
- CNSP $1.37
- Average True Range (ATR)
- EVTV 0.02
- CNSP 0.15
- MACD
- EVTV 0.01
- CNSP 0.07
- Stochastic Oscillator
- EVTV 46.67
- CNSP 44.82
About EVTV Envirotech Vehicles Inc.
Envirotech Vehicles Inc is a provider of purpose-built zero-emission electric vehicles focused on reducing the total cost of vehicle ownership and helping fleet operators unlock the benefits of green technology. It recognizes revenue from the sales of zero-emission electric vehicles and vehicle maintenance and inspection services. The Company serves commercial and last-mile fleets, school districts, public and private transportation service companies and colleges and universities to meet the increasing demand for light to heavy-duty electric vehicles.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.